Emergent Biosolutions (EBS) Com Stk USD0.001
Sell:$6.99Buy:$7.00
$0.12
(1.69%)
- This stock can be held in a
Stocks and Shares ISA$0.12
(1.69%)$0.12
(1.69%)Company Information
About this company
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.
Key people
Key facts
- EPICEBS
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINUS29089Q1058
- Market cap$385.92m
- Employees900
- Shares in issue59.88m
- ExchangeNew York Stock Exchange
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.